New Results Provide Glimpse Into BlissBio's Enhertu Challenger In HER2-Low Breast Cancer

 
• By Dexter Jie Yan
  
unlock potential
BlissBio hoping to unlock potential of BB-1701 for HER2-low breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia